SHIV infection protects against heterologous pathogenic SHIV challenge in macaques: A gold-standard for HIV-1 vaccine development?

Por Sealy, Robert, Zhan, Xiaoyan, Lockey, Timothy D., Martin, Louis, Blanchard, James, Traina-Dorge, Vicki, Hurwitz, Julia L.
Publicado em 2009

Localization of CD4(+) T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing

Por Surman, Sherri, Lockey, Timothy D., Slobod, Karen S., Jones, Bart, Riberdy, Janice M., White, Stephen W., Doherty, Peter C., Hurwitz, Julia L.
Publicado em 2001

Distribution of AAV8 particles in cell lysates and culture media changes with time and is dependent on the recombinant vector

Por Piras, Bryan A, Drury, Jason E, Morton, Christopher L, Spence, Yunyu, Lockey, Timothy D, Nathwani, Amit C, Davidoff, Andrew M, Meagher, Michael M
Publicado no Mol Ther Methods Clin Dev (2016)

Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials

Por Brown, Scott A., Surman, Sherri L., Sealy, Robert, Jones, Bart G., Slobod, Karen S., Branum, Kristen, Lockey, Timothy D., Howlett, Nanna, Freiden, Pamela, Flynn, Patricia, Hurwitz, Julia L.
Publicado em 2010

A Multi-Vector, Multi-Envelope HIV-1 Vaccine

Por Hurwitz, Julia L., Zhan, Xiaoyan, Brown, Scott A., Bonsignori, Mattia, Stambas, John, Lockey, Timothy D., Jones, Bart, Surman, Sherri, Sealy, Robert, Freiden, Pam, Branum, Kristen, Slobod, Karen S.
Publicado em 2007